Details for New Drug Application (NDA): 019436
✉ Email this page to a colleague
The generic ingredient in PRIMACOR is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
Summary for 019436
Tradename: | PRIMACOR |
Applicant: | Sanofi Aventis Us |
Ingredient: | milrinone lactate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019436
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 31, 1987 | TE: | RLD: | Yes |
Expired US Patents for NDA 019436
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | PRIMACOR | milrinone lactate | INJECTABLE;INJECTION | 019436-001 | Dec 31, 1987 | 4,313,951*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription